BPIQ Blog

May 21, 20191 min read

ARRY shows encouraging Ph3 data in BRAF mutant CRC

Congrats to ARRY on positive data for mutant BRAF colorectal cancer (CRC). This interim data should lead to FDA/EMA approvals in this...

Jun 23, 20181 min read

Congrats Array Biopharma on continued excellent data on its colorectal cancer (CRC) study of patients with BRAF V600E mutations with the...

Our platform helps you uncover your next biotech investment opportunity